Compositions useful in the diagnostic of latently infected Mycobacterium tuberculosis
US11448656B2 · kind B2 · utility
0Cited by
1References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 17, 2018 |
| Grant date | Sep 20, 2022 |
| Priority date | — |
| Expiry date | Oct 20, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/57
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention concerns a composition comprising at least three peptides derived from Mycobacterium tuberculosis antigen Rv2626c, its use in the diagnostic of latently infected Mycobacterium tuberculosis (LTBI) subjects, corresponding methods of use and kits.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.